Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

March 31, 2005

Study Completion Date

March 31, 2005

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

biphasic insulin aspart

DRUG

insulin glargine

DRUG

metformin

DRUG

glimepiride

Trial Locations (54)

1000

Novo Nordisk Investigational Site, Ljubljana

1041

Novo Nordisk Investigational Site, Budapest

2000

Novo Nordisk Investigational Site, Maribor

2483

Novo Nordisk Investigational Site, Ebreichsdorf

3000

Novo Nordisk Investigational Site, Celje

3300

Novo Nordisk Investigational Site, Eger

5010

Novo Nordisk Investigational Site, Salzburg

6807

Novo Nordisk Investigational Site, Feldkirch

7100

Novo Nordisk Investigational Site, Szekszárd

7350

Novo Nordisk Investigational Site, Oberpullendorf

8036

Novo Nordisk Investigational Site, Graz

16928

Novo Nordisk Investigational Site, Pritzwalk

22119

Novo Nordisk Investigational Site, Hamburg

22177

Novo Nordisk Investigational Site, Hamburg

35037

Novo Nordisk Investigational Site, Marburg

35043

Novo Nordisk Investigational Site, Marburg

36037

Novo Nordisk Investigational Site, Fulda

44577

Novo Nordisk Investigational Site, Castrop-Rauxel

44623

Novo Nordisk Investigational Site, Herne

45468

Novo Nordisk Investigational Site, Mülheim

46001

Novo Nordisk Investigational Site, Liberec

47053

Novo Nordisk Investigational Site, Duisburg

49179

Novo Nordisk Investigational Site, Ostercappeln

51377

Novo Nordisk Investigational Site, Leverkusen

52249

Novo Nordisk Investigational Site, Eschweiler

58452

Novo Nordisk Investigational Site, Witten

58456

Novo Nordisk Investigational Site, Witten

65691

Novo Nordisk Investigational Site, Brno

66299

Novo Nordisk Investigational Site, Friedrichsthal

66539

Novo Nordisk Investigational Site, Neunkirchen

66709

Novo Nordisk Investigational Site, Weiskirchen

67059

Novo Nordisk Investigational Site, Ludwigshafen

67063

Novo Nordisk Investigational Site, Ludwigshafen

68161

Novo Nordisk Investigational Site, Mannheim

68199

Novo Nordisk Investigational Site, Mannheim

68519

Novo Nordisk Investigational Site, Viernheim

71263

Novo Nordisk Investigational Site, Weil der Stadt

71634

Novo Nordisk Investigational Site, Ludwigsburg

73326

Novo Nordisk Investigational Site, Deggingen

74348

Novo Nordisk Investigational Site, Lauffen am Neckar

77971

Novo Nordisk Investigational Site, Kippenheim

83022

Novo Nordisk Investigational Site, Rosenheim

86150

Novo Nordisk Investigational Site, Augsburg

91054

Novo Nordisk Investigational Site, Erlangen

A 3580

Novo Nordisk Investigational Site, Horn

A 9500

Novo Nordisk Investigational Site, Villach

A 3830

Novo Nordisk Investigational Site, Waidhofen A.d. Thaya

42-200

Novo Nordisk Investigational Site, Częstochowa

81-366

Novo Nordisk Investigational Site, Gdynia

20 011

Novo Nordisk Investigational Site, Lublin

05-400

Novo Nordisk Investigational Site, Otwock

61-696

Novo Nordisk Investigational Site, Poznan

03491

Novo Nordisk Investigational Site, L'ubochna

036 59

Novo Nordisk Investigational Site, Martin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY